News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,633 Results
Type
Article (41067)
Company Profile (272)
Press Release (682283)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (205441)
Career Advice (2044)
Deals (35633)
Drug Delivery (110)
Drug Development (81417)
Employer Resources (174)
FDA (16424)
Job Trends (15007)
News (347360)
Policy (32796)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2579)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49901)
ALS (167)
Alzheimer's disease (1660)
Antibody-drug conjugate (ADC) (307)
Approvals (16689)
Artificial intelligence (508)
Autoimmune disease (143)
Automation (38)
Bankruptcy (361)
Best Places to Work (11691)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (177)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (633)
Cancer (4758)
Cardiovascular disease (395)
Career advice (1725)
Career pathing (35)
CAR-T (277)
CDC (44)
Celiac Disease (2)
Cell therapy (734)
Cervical cancer (36)
Clinical research (69512)
Collaboration (1681)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2714)
CRISPR (87)
C-suite (812)
Cystic fibrosis (143)
Data (6154)
Decentralized trials (2)
Denatured (26)
Depression (130)
Diabetes (495)
Diagnostics (6705)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (244)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90137)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (117604)
Executive appointments (967)
FDA (19497)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1447)
Gene editing (192)
Generative AI (42)
Gene therapy (587)
GLP-1 (965)
Government (4661)
Grass and pollen (6)
Guidances (383)
Healthcare (18954)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (54)
Indications (103)
Infectious disease (2972)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (243)
Interviews (323)
IPO (16663)
IRA (49)
Job creations (3653)
Job search strategy (1441)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (546)
Leadership (30)
Legal (7952)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (43)
Management (60)
Manufacturing (781)
MASH (161)
Medical device (13787)
Medtech (13839)
Mergers & acquisitions (20029)
Metabolic disorders (1252)
Multiple sclerosis (156)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2870)
Neurotech (1)
NextGen: Class of 2026 (6565)
Non-profit (4521)
Now hiring (65)
Obesity (587)
Opinion (257)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (223)
Parkinson's disease (280)
Partnered (33)
Patents (489)
Patient recruitment (469)
Peanut (55)
People (59090)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21670)
Phase 2 (30591)
Phase 3 (22797)
Pipeline (5081)
Policy (278)
Postmarket research (2566)
Preclinical (9198)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (278)
Rare diseases (814)
Real estate (5995)
Recruiting (69)
Regulatory (24477)
Reports (51)
Research institute (2405)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (148)
Series A (238)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3625)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (984)
Venture capital (86)
Weight loss (378)
Women's health (87)
Worklife (18)
Date
Last 7 days (595)
Last 30 days (2071)
Last 365 days (29818)
2026 (2823)
2025 (30271)
2024 (35314)
2023 (40170)
2022 (51290)
2021 (55867)
2020 (54289)
2019 (46847)
2018 (35212)
2017 (32260)
2016 (31634)
2015 (37694)
2014 (31441)
2013 (26465)
2012 (28685)
2011 (29379)
2010 (27417)
Location
Africa (742)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39335)
Australia (6430)
California (11170)
Canada (3253)
China (1082)
Colorado (471)
Connecticut (470)
Delaware (332)
Europe (84991)
Florida (1662)
Georgia (356)
Hawaii (3)
Idaho (62)
Illinois (852)
India (62)
Indiana (514)
Iowa (22)
Japan (418)
Kansas (126)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1376)
Massachusetts (8025)
Michigan (319)
Minnesota (625)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2968)
New Mexico (28)
New York (2947)
North Carolina (1439)
North Dakota (8)
Northern California (5441)
Ohio (332)
Oklahoma (21)
Oregon (42)
Pennsylvania (2256)
Puerto Rico (22)
Rhode Island (47)
South America (1111)
South Carolina (65)
South Dakota (1)
Southern California (4345)
Tennessee (173)
Texas (1720)
United States (39637)
Utah (334)
Vermont (1)
Virginia (258)
Washington D.C. (81)
Washington State (916)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
723,633 Results for "mynd analytics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.
MYND Life Sciences (CSE: MYND) (OTCQB: MYNDF) (“MYND” or the “Company”) The Company is pleased to welcome Ms.
January 30, 2024
·
3 min read
Press Releases
MYND Life Sciences Announces Shares for Debt Transaction
February 12, 2025
·
2 min read
Press Releases
NanoMosaic Secures FDA Advanced Manufacturing Technology (AMT) Designation for Advanced Gene Therapy Analytics
January 29, 2026
·
3 min read
Press Releases
MYND Life Sciences Announces Successful Conclusion of Debenture Settlement Agreement and Leadership Transition
January 10, 2025
·
2 min read
Press Releases
MYND Life Sciences Announces the Issuance of 4,000,001 Shares at $0.71/share
January 20, 2025
·
1 min read
Press Releases
Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection
February 4, 2026
·
4 min read
Press Releases
MYND Life Sciences Announces Strategic Debt Reduction and New Board Member Appointment
November 25, 2024
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer’s Risk Profiling
January 22, 2026
·
5 min read
Press Releases
MYND Life Sciences Announces Proposed Share Issuance to Remove Debenture and $3.440 M in debt on business
November 13, 2024
·
2 min read
1 of 72,364
Next
